Europe again postpones ban on specified risk materials
This article was originally published in Clinica
The European Council of Ministers has postponed for the fourth time the Commission's ban on the use of specified risk materials (SRMs), this time until June 30 2000. The ban, provided for in Commission Decision 97/534/EEC, was due to come into effect on January 1.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.